EPO and polycythemia: The major complications that were reported with erythropoietin include polycythemia, thrombo-embolic events,[27] hypertensive reactions,[27] and pure red cell aplasia.[28] We did not observe any significant change in hematocrit, platelet count, or any other clinical parameters that can be classified as adverse events.